How To Put $100 In Your Retirement Fund Each Month With Pfizer Stock

Benzinga
04-21

Pfizer (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the U.S. and internationally.

It will report its Q1 2025 earnings on April 29. Wall Street analysts expect the company to post EPS of $0.70, down from $0.82 in the prior-year period. According to data from Benzinga Pro, quarterly revenue is expected to be $14.27 billion, down from $14.88 billion a year earlier.

The 52-week range of Pfizer stock price was $20.92 to $31.54.

Pfizer's dividend yield is 7.66%. It paid $1.72 per share in dividends during the last 12 months.

Don't Miss:

  • Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!
  • Can you guess how many retire with a $5,000,000 nest egg? The percentage may shock you.

The Latest On Pfizer

On Feb. 4, the company announced its Q4 2024 earnings, posting adjusted EPS of $0.63, beating the consensus estimate of $0.47, as reported by Benzinga.

The U.S. drugmaker reported sales of $17.76 billion, up 22% year-over-year, and above the consensus of $17.40 billion.

Pfizer reaffirmed its full-year 2025 revenue guidance of $61 billion to $64 billion, compared to the consensus estimate of $63.025 billion. The company anticipates adjusted EPS in the range of $2.80 to $3.00, compared to the consensus of $2.94.

Trending: It’s no wonder Jeff Bezos holds over $250 million in art — this alternative asset has outpaced the S&P 500 since 1995, delivering an average annual return of 11.4%. Here’s how everyday investors are getting started.

How Can You Earn $100 Per Month As A Pfizer Investor?

If you want to make $100 per month — $1,200 annually — from Pfizer dividends, your investment value needs to be approximately $15,666, which is around 698 shares at $22.44 each. 

Understanding the dividend yield calculations: When making an estimate, you need two key variables — the desired annual income ($1,200) and the dividend yield (7.66% in this case). So, $1,200 / 0.0766 = $15,666 to generate an income of $100 per month.

You can calculate the dividend yield by dividing the annual dividend payments by the current price of the stock.

The dividend yield can change over time. This is the outcome of fluctuating stock prices and dividend payments on a rolling basis.

See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — invest pre-IPO from $0.60 per share now.

For instance, assume a stock that pays $2 as an annual dividend is priced at $50. Its dividend yield would be $2/$50 = 4%. If the stock price rises to $60, the dividend yield drops to 3.33% ($2/$60). A drop in stock price to $40 will have an inverse effect and increase the dividend yield to 5% ($2/$40).

In summary, income-focused investors may find Pfizer stock an attractive option for making a steady income of $100 per month by owning 698 shares of stock. There may be more upside to come as investors benefit from the company's consistent dividend hikes. Pfizer has raised its dividend consecutively for the last 14 years. 

Check out this article by Benzinga for three more stocks offering high dividend yields. 

Read Next:

  • This investment company boasts a 33.85% internal rate of return (IRR) for its realized projects, allowing accredited investors to earn passive returns and avoid the headaches of being a landlord.
  • ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.26/share with a $1000 minimum.

Image: Shutterstock

Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.

Get the latest stock analysis from Benzinga?

  • PFIZER (PFE): Free Stock Analysis Report

This article How To Put $100 In Your Retirement Fund Each Month With Pfizer Stock originally appeared on Benzinga.com

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10